Sarah Kerner Hare1, Kimberly Kraenow. 1. Hen House Pharmacy, 13600 S. Blackbob Rd., Olathe, KS 66062, USA. sarah.hare@ballsfoods.com
Abstract
OBJECTIVE: To develop a depression screening model that can be replicated by other community pharmacists, conduct a depression screening in a community pharmacy, identify and appropriately refer patients with symptoms consistent with depression. DESIGN: Uncontrolled study. SETTING: Four supermarkets in the Kansas City, Kans. and Mo" metropolitan area, on January 25, 2003. PARTICIPANTS: 18 supermarket shoppers, 6 community pharmacists, and 4 psychiatric pharmacy specialists. INTERVENTION: Identification of symptoms consistent with major depressive disorder (MDD). MAIN OUTCOME MEASURES: The feasibility and effectiveness of developed depression screening; identify and appropriately refer patients with symptoms consistent with depression. RESULTS: The depression screening model was tested as a pilot project to evaluate its feasibility and effectiveness. The mean (+/- SD) total score on the 10-item Harvard Department of Psychiatry/National Depression Screening Day Scale (HANDS) tool was 5.8 +/- 5.0. Overall, of 18 total participants, 14 were unlikely to have symptoms of MDD, 3 had symptoms consistent with MDD (including 1 reporting recent suicidal thinking), and 1 had symptoms strongly consistent with MDD. Patients followed the pharmacist's referral recommendations in all cases. CONCLUSION: The HANDS tool is easily used in community pharmacy as a screening form. With training, community pharmacists are capable of performing screenings and referring patients.
OBJECTIVE: To develop a depression screening model that can be replicated by other community pharmacists, conduct a depression screening in a community pharmacy, identify and appropriately refer patients with symptoms consistent with depression. DESIGN: Uncontrolled study. SETTING: Four supermarkets in the Kansas City, Kans. and Mo" metropolitan area, on January 25, 2003. PARTICIPANTS: 18 supermarket shoppers, 6 community pharmacists, and 4 psychiatric pharmacy specialists. INTERVENTION: Identification of symptoms consistent with major depressive disorder (MDD). MAIN OUTCOME MEASURES: The feasibility and effectiveness of developed depression screening; identify and appropriately refer patients with symptoms consistent with depression. RESULTS: The depression screening model was tested as a pilot project to evaluate its feasibility and effectiveness. The mean (+/- SD) total score on the 10-item Harvard Department of Psychiatry/National Depression Screening Day Scale (HANDS) tool was 5.8 +/- 5.0. Overall, of 18 total participants, 14 were unlikely to have symptoms of MDD, 3 had symptoms consistent with MDD (including 1 reporting recent suicidal thinking), and 1 had symptoms strongly consistent with MDD. Patients followed the pharmacist's referral recommendations in all cases. CONCLUSION: The HANDS tool is easily used in community pharmacy as a screening form. With training, community pharmacists are capable of performing screenings and referring patients.
Authors: Andrea L Murphy; Randa Ataya; Dani Himmelman; Claire O'Reilly; Alan Rosen; Luis Salvador-Carulla; Ruth Martin-Misener; Fred Burge; Stanley Kutcher; David M Gardner Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2018-06-23 Impact factor: 4.328
Authors: Andrea Lynn Murphy; Katelyn Hillier; Randa Ataya; Pierre Thabet; Anne Marie Whelan; Claire O'Reilly; David Gardner Journal: Can Pharm J (Ott) Date: 2017-10-05